Algert Global’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.92M Sell
272,910
-120,540
-31% -$932K 0.03% 732
2026
Q1
$2.51M Sell
393,450
-39,790
-9% -$277K 0.04% 654
2025
Q4
$3.05M Buy
433,240
+127,650
+42% +$770K 0.05% 596
2025
Q3
$1.68M Buy
+305,590
New +$1.5M 0.03% 727
2024
Q3
Sell
-11,508
Closed -$56.5K 1404
2024
Q2
$56.5K Buy
+11,508
New +$69.4K ﹤0.01% 1436

Other funds holding LFST

Algert Global's LFST Position: Q2 2026 in Review

Algert Global reduced its Lifestance Health (LFST) stake by 31% in Q2 2026, selling an estimated $932K and leaving 272,910 shares worth $2.92M. The position accounts for 0.03% of the portfolio, ranked #732.

Algert Global first reported a position in LFST in Q2 2024 and has held it in 5 quarters since. The position peaked at $3.05M in Q4 2025. 289 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • Algert Global held 272,910 shares of Lifestance Health worth $2.92M as of Q2 2026.
  • Algert Global sold 120,540 Lifestance Health shares in Q2 2026, an estimated $932K.
  • Lifestance Health made up 0.03% of Algert Global's portfolio in Q2 2026, its #732 holding.
  • Algert Global first reported a position in Lifestance Health in Q2 2024 and has held it in 5 quarters since.
  • Algert Global's Lifestance Health position peaked at $3.05M in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.